Sentara Medical Group

Norfolk, Virginia 23510

1 studies enrolling now · 27 studies all time

What they study most

Alzheimer's Disease, Aorta, Lesion, Aorta; Lesion, Aortic Aneurysm, Abdominal, Aortic Aneurysm, Thoracic, Aortoiliac Occlusive Disease, Arteriovenous Fistula, Arteriovenous Malformations, Cerebral, Arthritis, Rheumatoid, Chronic Kidney Disease, Critical Limb Ischemia, Diabetes

Studies at this site

• The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms — Running, not enrolling
• Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae — Running, not enrolling
• Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2 — Running, not enrolling
• Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of the Thoracoabdominal and Pararenal Aortic Aneurysms (TAMBE) — APPROVED_FOR_MARKETING
• Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System — Completed
• Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms — Running, not enrolling
• Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1 — Running, not enrolling
• Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• CXA-10 Study in Subjects With Pulmonary Arterial Hypertension — Stopped early
• PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) — Stopped early
• A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). — Stopped early
• A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) — Stopped early
• An Open-Label Crenezumab Study in Participants With Alzheimer's Disease — Stopped early
• Insulin Resistance Intervention After Stroke Trial — Completed
• A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease — Stopped early
• A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) — Stopped early
• A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries. — Completed
• Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program — Completed
• A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery — Completed
• A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors — Completed
• A Randomized Trial of Unruptured Brain AVMs — Completed
• A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease — Completed
• A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients — Completed
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up — Completed